These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 14569417)

  • 1. Synergistic effects of co-administration of angiotensin 1-7 and Neupogen on hematopoietic recovery in mice.
    Ellefson DD; diZerega GS; Espinoza T; Roda N; Maldonado S; Rodgers KE
    Cancer Chemother Pharmacol; 2004 Jan; 53(1):15-24. PubMed ID: 14569417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of angiotensin II and angiotensin(1-7) on hematopoietic recovery after intravenous chemotherapy.
    Rodgers K; Xiong S; DiZerega GS
    Cancer Chemother Pharmacol; 2003 Feb; 51(2):97-106. PubMed ID: 12647010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin-(1-7) synergizes with colony-stimulating factors in hematopoietic recovery.
    Rodgers KE; Espinoza TB; Roda N; Meeks CJ; diZerega GS
    Cancer Chemother Pharmacol; 2013 Dec; 72(6):1235-45. PubMed ID: 24091850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accelerated recovery from irradiation injury by angiotensin peptides.
    Rodgers KE; Xiong S; diZerega GS
    Cancer Chemother Pharmacol; 2002 May; 49(5):403-11. PubMed ID: 11976835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of hematopoietic myeloid and megakaryocyte toxicity associated with zidovudine in vivo in mice with recombinant GM-CSF.
    Gallicchio VS; Hughes NK; Tse KF
    Growth Regul; 1994 Jun; 4(2):41-7. PubMed ID: 7950902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined interleukin-1 beta/interleukin-6 treatment in mice: synergistic myelostimulatory activity and myelorestorative effect after cyclophosphamide-induced myelosuppression.
    Tritarelli E; Greco G; Testa U; Belardelli F; Peschle C; Proietti E
    Cancer Res; 1994 Dec; 54(24):6469-76. PubMed ID: 7987845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of murine hematopoiesis in vivo with recombinant murine interleukin-1.
    Gallicchio VS; Shedlofsky SI; Swim AT; Robinson JM; Hulette BC; Messino MJ; Doukas MA
    J Biol Response Mod; 1989 Aug; 8(4):422-39. PubMed ID: 2666587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin 1-induced sequential myelorestoration: dynamic relation between granulopoiesis and progenitor cell recovery in myelosuppressed mice.
    Ido M; Harada M; Furuichi H; Matsuoka N; Nakano K; Sohmura Y
    Exp Hematol; 1992 Feb; 20(2):161-6. PubMed ID: 1371964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the Cdk-inhibitor roscovitine on mouse hematopoietic progenitors in vivo and in vitro.
    Song H; Vita M; Sallam H; Tehranchi R; Nilsson C; Sidén A; Hassan Z
    Cancer Chemother Pharmacol; 2007 Nov; 60(6):841-9. PubMed ID: 17318617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
    Lemoli RM; Gulati SC
    Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of recombinant granulocyte colony-stimulating factor (rG-CSF) and recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF) on acute radiation hematopoietic injury in mice.
    Tanikawa S; Nakao I; Tsuneoka K; Nara N
    Exp Hematol; 1989 Sep; 17(8):883-8. PubMed ID: 2475360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of patients with multiple myeloma.
    Lemoli RM; Cavo M; Fortuna A
    J Hematother; 1996 Aug; 5(4):339-49. PubMed ID: 8877709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematologic effects of stem cell factor alone and in combination with G-CSF and GM-CSF in vivo and in vitro in rodents.
    Ulich TR; Yi ES; Yin S; del Castillo J; McNiece I; Yung YP; Zsebo KM
    Int Rev Exp Pathol; 1993; 34 Pt A():215-33. PubMed ID: 7681048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accelerated hematopoietic recovery with angiotensin-(1-7) after total body radiation.
    Rodgers KE; Espinoza T; Roda N; Meeks CJ; Hill C; Louie SG; Dizerega GS
    Int J Radiat Biol; 2012 Jun; 88(6):466-76. PubMed ID: 22433112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of short G-CSF administration on the numbers and clonogenic efficiency of hematopoietic progenitor cells in bone marrow and peripheral blood of normal donors.
    Zaucha JM; Knopińska-Posłuszny W; Bieniaszewska M; Myśliwski A; Hellmann A
    Ann Transplant; 2000; 5(4):20-6. PubMed ID: 11499355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increase in peripheral blood megakaryocyte progenitors following cancer therapy with high-dose cyclophosphamide and hematopoietic growth factors.
    Siena S; Bregni M; Bonsi L; Sklenar I; Bagnara GP; Bonadonna G; Gianni AM
    Exp Hematol; 1993 Nov; 21(12):1583-90. PubMed ID: 7691640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo effects of the immunosuppressant 15-deoxyspergualin on hematopoiesis in murine allogeneic bone marrow chimeras. Its thrombopoietic activity and reversal of adverse effects with granulocyte colony-stimulating factor and/or erythropoietin.
    Imamura M; Han M; Hashino S; Kobayashi H; Imai K; Kobayashi S; Tanaka J; Zhu X; Kobayashi M; Fujii Y
    Transplantation; 1994 Jul; 58(2):214-23. PubMed ID: 7518976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of cytokine treatment (granulocyte colony-stimulating factor and stem cell factor) on hematopoiesis and the circulating pool of hematopoietic stem cells in mice.
    Drize N; Chertkov J; Samoilina N; Zander A
    Exp Hematol; 1996 Jun; 24(7):816-22. PubMed ID: 8647232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of in vivo treatment with PIXY321 (GM-CSF/IL-3 fusion protein) on proliferation kinetics of bone marrow and blood myeloid progenitor cells in patients with sarcoma.
    Broxmeyer HE; Benninger L; Cooper S; Hague N; Benjamin RS; Vadhan-Raj S
    Exp Hematol; 1995 Apr; 23(4):335-40. PubMed ID: 7895781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.